Oscar Health, Inc. (OSCR) Operating Margin
- Operating margin · 12 months: Value 2128.95%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 2128.95% | Operating income / revenue. Period ending 2026-06-30. $629.72M ÷ $29.58M × 100 ≈ 2128.95% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 629.72M USD | Operating Income (Loss) |
| Revenue | 29.58M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | 2.43B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $629.72M | $29.58M | (m) | (m) | $2.43B | 2128.95% |
| 2026-03-31 | $10.61M | $29.98M | (m) | (m) | $2.27B | 35.37% |
| 2025-12-31 | $-396.36M | $28.59M | (m) | (m) | $2.05B | -1386.20% |
| 2025-09-30 | $-210.34M | $24.44M | (m) | (m) | $2.00B | -860.64% |
| 2025-06-30 | $-129.47M | $20.54M | (m) | (m) | $1.94B | -630.37% |
| 2025-03-31 | $168.83M | $19.27M | (m) | (m) | $1.84B | 876.04% |
| 2024-12-31 | $57.27M | $20.58M | (m) | (m) | $1.76B | 278.31% |
| 2024-09-30 | $59.52M | $15.58M | (m) | (m) | (m) | 382.10% |
| 2024-06-30 | $49.65M | $16.22M | (m) | (m) | (m) | 306.12% |
| 2024-03-31 | $-24.69M | $16.07M | (m) | (m) | (m) | -153.62% |
| 2023-12-31 | $-235.62M | $15.44M | (m) | (m) | (m) | -1525.81% |
| 2023-09-30 | $-312.62M | $14.29M | (m) | (m) | (m) | -2187.20% |
| 2023-06-30 | $-446.75M | $29.84M | (m) | (m) | (m) | -1496.98% |
| 2023-03-31 | $-546.70M | $46.44M | (m) | (m) | (m) | -1177.25% |
| 2022-12-31 | $-589.87M | $61.05M | (m) | (m) | (m) | -966.25% |
| 2022-09-30 | $-563.64M | $1.89B | (m) | (m) | (m) | -29.75% |
| 2022-06-30 | $-582.95M | $1.88B | (m) | (m) | (m) | -31.06% |
| 2022-03-31 | $-548.97M | $1.86B | (m) | (m) | (m) | -29.56% |
| 2021-12-31 | $-544.48M | $1.84B | (m) | (m) | (m) | -29.61% |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-402.27M | $462.80M | (m) | (m) | (m) | -86.92% |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-259.39M | $488.19M | (m) | (m) | (m) | -53.13% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.